Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biological Biomarkers in Respiratory Diseases.
García-Río F, Alcázar-Navarrete B, Castillo-Villegas D, Cilloniz C, García-Ortega A, Leiro-Fernández V, Lojo-Rodriguez I, Padilla-Galo A, Quezada-Loaiza CA, Rodriguez-Portal JA, Sánchez-de-la-Torre M, Sibila O, Martínez-García MA. García-Río F, et al. Arch Bronconeumol. 2022 Apr;58(4):323-333. doi: 10.1016/j.arbres.2022.01.003. Epub 2022 Jan 17. Arch Bronconeumol. 2022. PMID: 35312522 Free article. Review. English, Spanish.
Clinical audit of COPD patients requiring hospital admissions in Spain: AUDIPOC study.
Pozo-Rodríguez F, López-Campos JL, Alvarez-Martínez CJ, Castro-Acosta A, Agüero R, Hueto J, Hernández-Hernández J, Barrón M, Abraira V, Forte A, Sanchez Nieto JM, Lopez-Gabaldón E, Cosío BG, Agustí A; AUDIPOC Study Group. Pozo-Rodríguez F, et al. PLoS One. 2012;7(7):e42156. doi: 10.1371/journal.pone.0042156. Epub 2012 Jul 31. PLoS One. 2012. PMID: 22911875 Free PMC article.
"Correct use of inhaled corticosteroids in chronic obstructive pulmonary disease": a consensus document.
Alcázar Navarrete B, Casanova C, Miravitlles M, de Lucas P, Riesco JA, Rodríguez González-Moro JM; Working Group “Consensus document on the appropriate use of inhaled corticosteroids in COPD”. Alcázar Navarrete B, et al. Arch Bronconeumol. 2015 Apr;51(4):193-8. doi: 10.1016/j.arbres.2014.11.001. Epub 2014 Dec 23. Arch Bronconeumol. 2015. PMID: 25540900 English, Spanish.
The Future of Triple Therapy in chronic obstructive pulmonary disease.
Alcázar-Navarrete B, Castellano Miñán F, Romero Palacios PJ. Alcázar-Navarrete B, et al. Arch Bronconeumol (Engl Ed). 2018 Feb;54(2):63-64. doi: 10.1016/j.arbres.2017.06.019. Epub 2017 Jul 29. Arch Bronconeumol (Engl Ed). 2018. PMID: 28760570 English, Spanish. No abstract available.
Medical Care According to Risk Level and Adaptation to Spanish COPD Guidelines (Gesepoc): The Epoconsul Study.
Calle Rubio M, Rodríguez Hermosa JL, Soler-Cataluña JJ, López-Campos JL, Alcazar Navarrete B, Soriano JB, Rodríguez Gónzalez-Moro JM, Fuentes Ferrer ME, Miravitlles M; y el Grupo Epoconsul. Calle Rubio M, et al. Arch Bronconeumol (Engl Ed). 2018 May;54(5):270-279. doi: 10.1016/j.arbres.2017.11.015. Epub 2018 Feb 1. Arch Bronconeumol (Engl Ed). 2018. PMID: 29361320 English, Spanish.
Cost-effectiveness analysis of umeclidinium bromide/vilanterol 62.5/25 mcg versus tiotropium/olodaterol 5/5 mcg in symptomatic patients with chronic obstructive pulmonary disease: a Spanish National Healthcare System perspective.
Driessen MT, Whalen J, Seewoodharry Buguth B, Vallejo-Aparicio LA, Naya IP, Asukai Y, Alcázar-Navarrete B, Miravitlles M, García-Río F, Risebrough NA. Driessen MT, et al. Respir Res. 2018 Nov 20;19(1):224. doi: 10.1186/s12931-018-0916-7. Respir Res. 2018. PMID: 30458866 Free PMC article. Clinical Trial.
Patients with Chronic Obstructive Pulmonary Disease Exacerbations: Recommendations for Diagnosis, Treatment and Care.
Alcázar Navarrete B, Ancochea Bermúdez J, García-Río F, Izquierdo Alonso JL, Miravitlles M, Rodríguez González-Moro JM, Soler-Cataluña JJ. Alcázar Navarrete B, et al. Arch Bronconeumol (Engl Ed). 2019 Sep;55(9):478-487. doi: 10.1016/j.arbres.2019.02.020. Epub 2019 Apr 6. Arch Bronconeumol (Engl Ed). 2019. PMID: 30967279 English, Spanish.
65 results